Telomir Pharmaceuticals TELO 深 沪
等待开盘 11-21 09:30:00 美东时间
1.39
-0.040
-2.80%
华盛通- 最 高1.47
- 今 开1.46
- 成交量 33.63万股
- 最 低 1.375
- 昨 收 1.43
- 总市值 4778.96万
- 52周最高 7.0791
- 市盈率 静 --
- 换手率 0.98%
- 52周最低 1.12
- 委 比 50.19%
- 总股本 3438.10万
- 历史最高 20.72
- 量 比 1.30
- 振 幅 6.64%
- 历史最低 1.12
- 每 手 1
- 风险率 1.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Telomir Pharmaceuticals Announces Telomir-1 Shown To Kill Aggressive Human Leukemia Cells
Telomir Pharmaceuticals Announces Telomir-1 Kills Aggressive Human Leukemia Cells The findings expand Telomir-1's oncology profile into cancers of the blood, adding to previously reported activity in triple-negative
今天 05:05
Telomir Pharmaceuticals Q3 EPS $(0.03) Beats $(0.07) Estimate
Telomir Pharmaceuticals (NASDAQ:TELO) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 85 percent increase over losses of $(0.20) per share
11-11 07:00
Telomir Pharmaceuticals Unveils Promising Preclinical Cancer Data
The latest announcement is out from Telomir Pharmaceuticals, Inc. ( ($TELO) ). ...
10-23 04:40
Telomir Pharmaceuticals executes LOI for worldwide rights to Telomir-1
Telomir Pharmaceuticals (NASDAQ:TELO) said on Tuesday that it has executed a binding Letter of Intent to acquire TELI Pharmaceuticals, securing worldwide rights to its lead investigational therapy, T...
10-21 20:10
Telomir Pharmaceuticals to Acquire TELI Pharmaceuticals
The latest update is out from Telomir Pharmaceuticals, Inc. ( ($TELO) ). On Oct...
10-21 06:26
Telomir-1 Demonstrates Anti-Tumor Activity In Pancreatic Cancer Models, Reinforcing Epigenetic And Metabolic Impact Across Multiple Cancers
Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1's consistent impact on cancer cell survival pathways.MIAMI, FLORIDA / ACCESS
10-14 20:10
Telomir Pharmaceuticals Unveils Promising Pancreatic Cancer Findings
Telomir Pharmaceuticals, Inc. ( ($TELO) ) has provided an update. Telomir Pharm...
10-14 19:59
Geron announces executive leadership changes, new appointments
Geron Corporation (NASDAQ:GERN) on Monday said it will make several executive leadership changes this month as part of a restructuring to align with its commercial priorities. Chief Operating Officer ...
10-14 04:44
Geron's COO Andrew Grethlein To Depart On October 15, 2025
FOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced several
10-14 04:42
Market-Moving News for October 7th
TMQ: 230% | Shares of mining companies that operate in Alaska are trading higher after President Trump signed an executive order to build a 211-mile access road to the Ambler Mining District. NAK: 49% |
10-07 19:20
